|
|
N/A
|
7.4M
$0
|
|
|
|
N/A
|
10.9K
$0
|
|
|
|
N/A
|
162K
$0
|
|
Halozyme Therapeutics Inc
|
|
N/A
|
10.8M
$0
|
|
Halozyme Therapeutics Inc
|
|
N/A
|
9.8M
$0
|
|
|
|
N/A
|
46.2K
$0
|
|
|
|
N/A
|
5.2M
$0
|
|
|
|
N/A
|
2.07K
$0
|
|
|
|
N/A
|
3.91K
$0
|
|
|
|
N/A
|
1.01K
$0
|
|
|
|
$12.43 - $18.91
$584 - $889
|
57
$0
|
|
|
|
$0.27 - $0.34
$27.8 - $35
|
108
$0
|
|
|
|
N/A
|
39.1K
$0
|
|
|
|
N/A
|
85
$0
|
|
|
|
N/A
|
4.83M
$0
|
|
|
|
$49.98 - $50.26
$200 - $201
|
5
$0
|
|
|
|
$45.73 - $47.2
$137 - $142
|
14
$0
|
|
Invesco Actively Managed Exc
|
|
N/A
|
61
$0
|
|
Invesco Exch Traded Fd Tr Ii
|
|
N/A
|
278
$0
|
|
|
|
$14.41 - $16.7
$216 - $251
|
38
$0
|
|
|
|
$18.96 - $20.43
$19 - $20.4
|
47
$0
|
|
|
|
$21.12 - $22.45
$63.4 - $67.4
|
4
$0
|
|
|
|
$12.13 - $13.94
$121 - $139
|
11
$0
|
|
Invesco Exch Trd Slf Idx Fd
|
|
N/A
|
2
$0
|
|
|
|
N/A
|
6.61K
$0
|
|
|
|
N/A
|
728
$0
|
|
Invesco Exchange Traded Fd T
|
|
N/A
|
258
$0
|
|
|
|
N/A
|
1.11K
$0
|
|
Invesco Exchange Traded Fd T
|
|
N/A
|
173
$0
|
|
|
|
N/A
|
48.6K
$0
|
|
|
|
N/A
|
1.76K
$0
|
|
|
|
N/A
|
153
$0
|
|
|
|
N/A
|
38.1K
$0
|
|
|
|
N/A
|
500
$0
|
|
J P Morgan Exchange Traded F
|
|
N/A
|
9
$0
|
|
|
|
N/A
|
83.9K
$0
|
|
|
|
N/A
|
4.88K
$0
|
|
|
|
N/A
|
18.9K
$0
|
|
Karyopharm Therapeutics Inc
|
|
N/A
|
765
$0
|
|
|
|
N/A
|
1.83M
$0
|
|
Kestra Med Technologies LTD
|
|
N/A
|
3.7M
$0
|
|
|
|
N/A
|
22.7K
$0
|
|
Kindercare Learning Companie
|
|
N/A
|
3.4M
$0
|
|
Kiniksa Pharmaceuticals Intl
|
|
N/A
|
807K
$0
|
|
|
|
N/A
|
1.33M
$0
|
|
|
|
N/A
|
1.53M
$0
|
|
|
|
N/A
|
963K
$0
|
|
|
|
N/A
|
8.18K
$0
|
|
|
|
N/A
|
16.3M
$0
|
|
|
|
N/A
|
11.3M
$0
|
|